Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
Abstract
:1. Introduction
2. Nut Consumption: Beneficial Metabolic Effects
3. Nut Consumption and Cardio-Vascular Disease
4. Nuts and NAFLD
5. Potential Harms of Nut Consumption in the NAFLD Population: Aflatoxin Contamination
6. Conclusions
Author Contributions
Funding
Conflicts of Interest
Data Literature Search Strategy
References
- Singh, S.; Allen, A.M.; Wang, Z.; Prokop, L.J.; Murad, M.H.; Loomba, R. Fibrosis progression in nonalcoholic fatty liver vs. nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies. Clin. Gastroenterol. Hepatol. 2015, 13, 643–654.e9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Younossi, Z.; Anstee, Q.M.; Marietti, M.; Hardy, T.; Henry, L.; Eslam, M.; George, J.; Bugianesi, E. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 2018, 15, 11–20. [Google Scholar] [CrossRef] [PubMed]
- Younossi, Z.; Tacke, F.; Arrese, M.; Chander Sharma, B.; Mostafa, I.; Bugianesi, E.; Wai-Sun Wong, V.; Yilmaz, Y.; George, J.; Fan, J.; et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology 2019, 69, 2672–2682. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- European Association for the Study of the Liver; European Association for the Study of Diabetes; European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 2016, 59, 1121–1140. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mediterranean Diet for Primary Prevention of Cardio-vascular Disease. N. Engl. J. Med. 2013, 369, 672–677. [CrossRef] [PubMed]
- Kastorini, C.-M.; Milionis, H.J.; Esposito, K.; Giugliano, D.; Goudevenos, J.A.; Panagiotakos, D.B. The Effect of Mediterranean Diet on Metabolic Syndrome and its Components: A Meta-Analysis of 50 Studies and 534,906 Individuals. J. Am. Coll. Cardiol. 2011, 57, 1299–1313. [Google Scholar] [CrossRef] [Green Version]
- Properzi, C.; O’Sullivan, T.A.; Sherriff, J.L.; Ching, H.L.; Jeffrey, G.P.; Buckley, R.F.; Tibballs, J.; MacQuillan, G.C.; Garas, G.; Adams, L.A. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial. Hepatology 2018, 68, 1741–1754. [Google Scholar] [CrossRef] [Green Version]
- Gepner, Y.; Shelef, I.; Komy, O.; Cohen, N.; Schwarzfuchs, D.; Bril, N.; Rein, M.; Serfaty, D.; Kenigsbuch, S.; Zelicha, H.; et al. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. J. Hepatol. 2019, 71, 379–388. [Google Scholar] [CrossRef] [Green Version]
- Kontogianni, M.D.; Tileli, N.; Margariti, A.; Georgoulis, M.; Deutsch, M.; Tiniakos, D.; Fragopoulou, E.; Zafiropoulou, R.; Manios, Y.; Papatheodoridis, G. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin. Nutr. 2014, 33, 678–683. [Google Scholar] [CrossRef]
- Torres, M.C.P.; Aghemo, A.; Lleo, A.; Bodini, G.; Furnari, M.; Marabotto, E.; Miele, L.; Giannini, E.G. Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered. Nutrients 2019, 11, 2971. [Google Scholar] [CrossRef] [Green Version]
- Bach-Faig, A.; Berry, E.M.; Lairon, D.; Reguant, J.; Trichopoulou, A.; Dernini, S.; Medina, F.X.; Battino, M.; Belahsen, R.; Miranda, G.; et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011, 14, 2274–2284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Esposito, K.; Kastorini, C.-M.; Panagiotakos, D.B.; Giugliano, D. Mediterranean diet and metabolic syndrome: An updated systematic review. Rev. Endocr. Metab. Disord. 2013, 14, 255–263. [Google Scholar] [CrossRef]
- Venkatachalam, M.; Sathe, S.K. Chemical composition of selected edible nut seeds. J. Agric. Food Chem. 2006, 54, 4705–4714. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.; Keogh, J.B.; Clifton, P.M. Benefits of Nut Consumption on Insulin Resistance and Cardio-vascular Risk Factors: Multiple Potential Mechanisms of Actions. Nutrients 2017, 9, 1271. [Google Scholar] [CrossRef] [Green Version]
- Coates, A.M.; Hill, A.M.; Tan, S.Y. Nuts and Cardio-vascular Disease Prevention. Curr. Atheroscler. Rep. 2018, 20, 48. [Google Scholar] [CrossRef] [PubMed]
- Targher, G.; Byrne, C.D.; Lonardo, A.; Zoppini, G.; Barbui, C. Non-alcoholic fatty liver disease and risk of incident cardio-vascular disease: A meta-analysis. J. Hepatol. 2016, 65, 589–600. [Google Scholar] [CrossRef] [Green Version]
- Ekstedt, M.; Hagstrom, H.; Nasr, P.; Fredrikson, M.; Stal, P.; Kechagias, S.; Hultcrantz, R. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015, 61, 1547–1554. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Del Gobbo, L.C.; Falk, M.C.; Feldman, R.; Lewis, K.; Mozaffarian, D. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: Systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am. J. Clin. Nutr. 2015, 102, 1347–1356. [Google Scholar] [CrossRef] [Green Version]
- Sabaté, J.; Oda, K.; Ros, E. Nut Consumption and Blood Lipid Levels: A Pooled Analysis of 25 Intervention Trials. Arch. Intern. Med. 2010, 170, 821–827. [Google Scholar] [CrossRef] [Green Version]
- Ruisinger, J.F.; Gibson, C.A.; Backes, J.M.; Smith, B.K.; Sullivan, D.K.; Moriarty, P.M.; Kris-Etherton, P. Statins and almonds to lower lipoproteins (the STALL Study). J. Clin. Lipidol. 2015, 9, 58–64. [Google Scholar] [CrossRef]
- Azad, B.J.; Daneshzad, E.; Azadbakht, L. Peanut and cardio-vascular disease risk factors: A systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 2020, 60, 1123–1140. [Google Scholar] [CrossRef]
- Kendall, C.W.; Esfahani, A.; Truan, J.; Srichaikul, K.; Jenkins, D.J. Health benefits of nuts in prevention and management of diabetes. Asia Pac. J. Clin. Nutr. 2010, 19, 110–116. [Google Scholar] [PubMed]
- Viguiliouk, E.; Kendall, C.W.C.; Blanco Mejia, S.; Cozma, A.I.; Ha, V.; Mirrahimi, A.; Jayalath, V.H.; Augustin, L.S.A.; Chiavaroli, L.; Leiter, L.A.; et al. Effect of Tree Nuts on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Dietary Trials. PLoS ONE 2014, 9, e103376. [Google Scholar] [CrossRef] [PubMed]
- Reis, C.E.G.; Ribeiro, D.N.; Costa, N.M.B.; Bressan, J.; Alfenas, R.C.G.; Mattes, R.D. Acute and second-meal effects of peanuts on glycaemic response and appetite in obese women with high type 2 diabetes risk: A randomised cross-over clinical trial. Br. J. Nutr. 2013, 109, 2015–2023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Johnston, C.S.; Buller, A.J. Vinegar and Peanut Products as Complementary Foods to Reduce Postprandial Glycemia. J. Am. Diet. Assoc. 2005, 105, 1939–1942. [Google Scholar] [CrossRef] [PubMed]
- Parham, M.; Heidari, S.; Khorramirad, A.; Hozoori, M.; Hosseinzadeh, F.; Bakhtyari, L.; Vafaeimanesh, J. Effects of pistachio nut supplementation on blood glucose in patients with type 2 diabetes: A randomized crossover trial. Rev. Diabet Stud. 2014, 11, 190–196. [Google Scholar] [CrossRef] [Green Version]
- Sauder, K.A.; McCrea, C.E.; Ulbrecht, J.S.; Kris-Etherton, P.M.; West, S.G. Effects of pistachios on the lipid/lipoprotein profile, glycemic control, inflammation, and endothelial function in type 2 diabetes: A randomized trial. Metab. Clin. Exp. 2015, 64, 1521–1529. [Google Scholar] [CrossRef] [Green Version]
- Mori, A.M.; Considine, R.V.; Mattes, R.D. Acute and second-meal effects of almond form in impaired glucose tolerant adults: A randomized crossover trial. Nutr. Metab. 2011, 8, 6. [Google Scholar] [CrossRef] [Green Version]
- Jenkins, D.J.A.; Kendall, C.W.C.; Josse, A.R.; Salvatore, S.; Brighenti, F.; Augustin, L.S.A.; Ellis, P.R.; Vidgen, E.; Rao, A.V. Almonds Decrease Postprandial Glycemia, Insulinemia, and Oxidative Damage in Healthy Individuals. J. Nutr. 2006, 136, 2987–2992. [Google Scholar] [CrossRef] [Green Version]
- Wien, M.; Bleich, D.; Raghuwanshi, M.; Gould-Forgerite, S.; Gomes, J.; Monahan-Couch, L.; Oda, K. Almond consumption and cardio-vascular risk factors in adults with prediabetes. J. Am. Coll. Nutr. 2010, 29, 189–197. [Google Scholar] [CrossRef]
- Qian, F.; Korat, A.A.; Malik, V.; Hu, F.B. Metabolic Effects of Monounsaturated Fatty Acid–Enriched Diets Compared With Carbohydrate or Polyunsaturated Fatty Acid–Enriched Diets in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2016, 39, 1448–1457. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Salas-Salvadó, J.; Bulló, M.; Babio, N.; Martínez-González, M.Á.; Ibarrola-Jurado, N.; Basora, J.; Estruch, R.; Covas, M.I.; Corella, D.; Arós, F.; et al. Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet. Diabetes Care 2011, 34, 14–19. [Google Scholar] [CrossRef] [Green Version]
- Mirabelli, M.; Chiefari, E.; Arcidiacono, B.; Corigliano, D.M.; Brunetti, F.S.; Maggisano, V.; Russo, D.; Foti, D.P.; Brunetti, A. Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases. Nutrients 2020, 12, 1066. [Google Scholar] [CrossRef] [Green Version]
- Xiong, Y.; Swaminath, G.; Cao, Q.; Yang, L.; Guo, Q.; Salomonis, H.; Lu, J.; Houze, J.B.; Dransfield, P.J.; Wang, Y.; et al. Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1. Mol. Cell. Endocrinol. 2013, 369, 119–129. [Google Scholar] [CrossRef] [PubMed]
- Fang, X.-L.; Shu, G.; Zhang, Z.-Q.; Wang, S.-B.; Zhu, X.-T.; Gao, P.; Xi, Q.-Y.; Zhang, Y.-L.; Jiang, Q.-Y. Roles of α-linolenic acid on IGF-I secretion and GH/IGF system gene expression in porcine primary hepatocytes. Mol. Biol. Rep. 2012, 39, 10987–10996. [Google Scholar] [CrossRef] [PubMed]
- Wien, M.A.; Sabaté, J.M.; Iklé, D.N.; Cole, S.E.; Kandeel, F.R. Almonds vs. complex carbohydrates in a weight reduction program. Int. J. Obes. 2003, 27, 1365–1372. [Google Scholar] [CrossRef] [Green Version]
- Razquin, C.; Sanchez-Tainta, A.; Salas-Salvadó, J.; Buil-Cosiales, P.; Corella, D.; Fito, M.; Ros, E.; Estruch, R.; Arós, F.; Gómez-Gracia, E.; et al. Dietary energy density and body weight changes after 3 years in the PREDIMED study. Int. J. Food Sci. Nutr. 2017, 68, 865–872. [Google Scholar] [CrossRef]
- Agebratt, C.; Strom, E.; Romu, T.; Dahlqvist-Leinhard, O.; Borga, M.; Leandersson, P.; Nystrom, F.H. A Randomized Study of the Effects of Additional Fruit and Nuts Consumption on Hepatic Fat Content, Cardio-vascular Risk Factors and Basal Metabolic Rate. PLoS ONE 2016, 11, e0147149. [Google Scholar] [CrossRef]
- Bes-Rastrollo, M.; Sabaté, J.; Gómez-Gracia, E.; Alonso, A.; Martínez, J.A.; Martínez-González, M.A. Nut Consumption and Weight Gain in a Mediterranean Cohort: The SUN Study. Obesity 2007, 15, 107. [Google Scholar] [CrossRef]
- Bes-Rastrollo, M.; Wedick, N.M.; Martinez-Gonzalez, M.A.; Li, T.Y.; Sampson, L.; Hu, F.B. Prospective study of nut consumption, long-term weight change, and obesity risk in women. Am. J. Clin. Nutr. 2009, 89, 1913–1919. [Google Scholar] [CrossRef]
- Casas-Agustench, P.; Bulló, M.; Ros, E.; Basora, J.; Salas-Salvadó, J. Cross-sectional association of nut intake with adiposity in a Mediterranean population. Nutr. Metab. Cardio-Vasc. Dis. 2011, 21, 518–525. [Google Scholar] [CrossRef] [PubMed]
- Tan, S.Y.; Mattes, R.D. Appetitive, dietary and health effects of almonds consumed with meals or as snacks: A randomized, controlled trial. Eur. J. Clin. Nutr. 2013, 67, 1205–1214. [Google Scholar] [CrossRef] [Green Version]
- Hull, S.; Re, R.; Chambers, L.; Echaniz, A.; Wickham, M.S.J. A mid-morning snack of almonds generates satiety and appropriate adjustment of subsequent food intake in healthy women. Eur. J. Nutr. 2015, 54, 803–810. [Google Scholar] [CrossRef] [Green Version]
- Pasman, W.J.; Heimerikx, J.; Rubingh, C.M.; van den Berg, R.; O’Shea, M.; Gambelli, L.; Hendriks, H.F.J.; Einerhand, A.W.C.; Scott, C.; Keizer, H.G.; et al. The effect of Korean pine nut oil on in vitro CCK release, on appetite sensations and on gut hormones in post-menopausal overweight women. Lipids Health Dis. 2008, 7, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- George, E.S.; Forsyth, A.; Itsiopoulos, C.; Nicoll, A.J.; Ryan, M.; Sood, S.; Roberts, S.K.; Tierney, A.C. Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults. Adv. Nutr. 2018, 9, 30–40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Holscher, H.D.; Guetterman, H.M.; Swanson, K.S.; An, R.; Matthan, N.R.; Lichtenstein, A.H.; Novotny, J.A.; Baer, D.J. Walnut Consumption Alters the Gastrointestinal Microbiota, Microbially Derived Secondary Bile Acids, and Health Markers in Healthy Adults: A Randomized Controlled Trial. J. Nutr. 2018, 148, 861–867. [Google Scholar] [CrossRef]
- Holscher, H.D.; Taylor, A.M.; Swanson, K.S.; Novotny, J.A.; Baer, D.J. Almond Consumption and Processing Affects the Composition of the Gastrointestinal Microbiota of Healthy Adult Men and Women: A Randomized Controlled Trial. Nutrients 2018, 10, 126. [Google Scholar] [CrossRef] [Green Version]
- Karlsson, F.H.; Fåk, F.; Nookaew, I.; Tremaroli, V.; Fagerberg, B.; Petranovic, D.; Bäckhed, F.; Nielsen, J. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 2012, 3, 1245. [Google Scholar] [CrossRef] [Green Version]
- Adashek, J.J.; Redding, D. A Pilot Study on the Effects of Nut Consumption on Cardio-vascular Biomarkers. Cureus 2020, 12, e8798. [Google Scholar] [CrossRef]
- Mazidi, M.; Vatanparast, H.; Katsiki, N.; Banach, M. The impact of nuts consumption on glucose/insulin homeostasis and inflammation markers mediated by adiposity factors among American adults. Oncotarget 2018, 9, 31173–31186. [Google Scholar] [CrossRef] [Green Version]
- Yu, Z.; Malik, V.S.; Keum, N.; Hu, F.B.; Giovannucci, E.L.; Stampfer, M.J.; Willett, W.C.; Fuchs, C.S.; Bao, Y. Associations between nut consumption and inflammatory biomarkers. Am. J. Clin. Nutr. 2016, 104, 722–728. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Medina-Remón, A.; Casas, R.; Tressserra-Rimbau, A.; Ros, E.; Martínez-González, M.A.; Fitó, M.; Corella, D.; Salas-Salvadó, J.; Lamuela-Raventos, R.M.; Estruch, R. Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: A substudy of the PREDIMED trial. Br. J. Clin. Pharmacol. 2017, 83, 114–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Buzzetti, E.; Pinzani, M.; Tsochatzis, E.A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016, 65, 1038–1048. [Google Scholar] [CrossRef]
- Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.-I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; et al. Primary Prevention of Cardio-vascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N. Engl. J. Med. 2018, 378, e34. [Google Scholar] [CrossRef] [PubMed]
- Gopinath, B.; Flood, V.M.; Burlutksy, G.; Mitchell, P. Consumption of nuts and risk of total and cause-specific mortality over 15 years. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 1125–1131. [Google Scholar] [CrossRef] [PubMed]
- Guasch-Ferre, M.; Liu, X.; Malik, V.S.; Sun, Q.; Willett, W.C.; Manson, J.E.; Rexrode, K.M.; Li, Y.; Hu, F.B.; Bhupathiraju, S.N. Nut Consumption and Risk of Cardio-vascular Disease. J. Am. Coll. Cardiol. 2017, 70, 2519–2532. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Guasch-Ferre, M.; Drouin-Chartier, J.P.; Tobias, D.K.; Bhupathiraju, S.N.; Rexrode, K.M.; Willett, W.C.; Sun, Q.; Li, Y. Changes in Nut Consumption and Subsequent Cardio-vascular Disease Risk Among US Men and Women: 3 Large Prospective Cohort Studies. J. Am. Heart Assoc. 2020, 9, e013877. [Google Scholar] [CrossRef]
- Luu, H.N.; Blot, W.J.; Xiang, Y.B.; Cai, H.; Hargreaves, M.K.; Li, H.; Yang, G.; Signorello, L.; Gao, Y.T.; Zheng, W.; et al. Prospective evaluation of the association of nut/peanut consumption with total and cause-specific mortality. Jama Intern. Med. 2015, 175, 755–766. [Google Scholar] [CrossRef]
- Van den Brandt, P.A.; Schouten, L.J. Relationship of tree nut, peanut and peanut butter intake with total and cause-specific mortality: A cohort study and meta-analysis. Int. J. Epidemiol. 2015, 44, 1038–1049. [Google Scholar] [CrossRef] [Green Version]
- Bao, Y.; Han, J.; Hu, F.B.; Giovannucci, E.L.; Stampfer, M.J.; Willett, W.C.; Fuchs, C.S. Association of nut consumption with total and cause-specific mortality. N. Engl. J. Med. 2013, 369, 2001–2011. [Google Scholar] [CrossRef] [Green Version]
- Hshieh, T.T.; Petrone, A.B.; Gaziano, J.M.; Djousse, L. Nut consumption and risk of mortality in the Physicians’ Health Study. Am. J. Clin. Nutr. 2015, 101, 407–412. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Amba, V.; Murphy, G.; Etemadi, A.; Wang, S.; Abnet, C.C.; Hashemian, M. Nut and Peanut Butter Consumption and Mortality in the National Institutes of Health-AARP Diet and Health Study. Nutrients 2019, 11, 1508. [Google Scholar] [CrossRef] [Green Version]
- Mayhew, A.J.; de Souza, R.J.; Meyre, D.; Anand, S.S.; Mente, A. A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality. Br. J. Nutr. 2016, 115, 212–225. [Google Scholar] [CrossRef]
- Grosso, G.; Yang, J.; Marventano, S.; Micek, A.; Galvano, F.; Kales, S.N. Nut consumption on all-cause, cardio-vascular, and cancer mortality risk: A systematic review and meta-analysis of epidemiologic studies. Am. J. Clin. Nutr. 2015, 101, 783–793. [Google Scholar] [CrossRef] [Green Version]
- Aune, D.; Keum, N.; Giovannucci, E.; Fadnes, L.T.; Boffetta, P.; Greenwood, D.C.; Tonstad, S.; Vatten, L.J.; Riboli, E.; Norat, T. Nut consumption and risk of cardio-vascular disease, total cancer, all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016, 14, 207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Asbaghi, O.; Emamat, H.; Kelishadi, M.R.; Hekmatdoost, A. The Association between Nuts Intake and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Case-Control Study. Clin. Nutr. Res. 2020, 9, 195–204. [Google Scholar] [CrossRef] [PubMed]
- Eslamparast, T.; Sharafkhah, M.; Poustchi, H.; Hashemian, M.; Dawsey, S.M.; Freedman, N.D.; Boffetta, P.; Abnet, C.C.; Etemadi, A.; Pourshams, A.; et al. Nut consumption and total and cause-specific mortality: Results from the Golestan Cohort Study. Int. J. Epidemiol. 2017, 46, 75–85. [Google Scholar] [CrossRef] [Green Version]
- Zelber-Sagi, S.; Salomone, F.; Mlynarsky, L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int. 2017, 37, 936–949. [Google Scholar] [CrossRef] [Green Version]
- Chen, B.B.; Han, Y.; Pan, X.; Yan, J.; Liu, W.; Li, Y.; Lin, X.; Xu, S.; Peng, X.E. Association between nut intake and non-alcoholic fatty liver disease risk: A retrospective case-control study in a sample of Chinese Han adults. BMJ Open 2019, 9, e028961. [Google Scholar] [CrossRef] [PubMed]
- Zhang, S.; Fu, J.; Zhang, Q.; Liu, L.; Meng, G.; Yao, Z.; Wu, H.; Bao, X.; Gu, Y.; Lu, M.; et al. Association between nut consumption and non-alcoholic fatty liver disease in adults. Liver Int. 2019, 39, 1732–1741. [Google Scholar] [CrossRef]
- Han, J.M.; Jo, A.N.; Lee, S.M.; Bae, H.S.; Jun, D.W.; Cho, Y.K.; Suk, K.T.; Yoon, J.H.; Ahn, S.B.; Cho, Y.J.; et al. Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 2014, 29, 1265–1272. [Google Scholar] [CrossRef] [PubMed]
- Cueto-Galán, R.; Barón, F.J.; Valdivielso, P.; Pintó, X.; Corbella, E.; Gómez-Gracia, E.; Wärnberg, J. Changes in fatty liver index after consuming a Mediterranean diet: 6-year follow-up of the PREDIMED-Malaga trial. Med. Clin. Barc. 2017, 148, 435–443. [Google Scholar] [CrossRef] [PubMed]
- Bowen, J.; Luscombe-Marsh, N.D.; Stonehouse, W.; Tran, C.; Rogers, G.B.; Johnson, N.; Thompson, C.H.; Brinkworth, G.D. Effects of almond consumption on metabolic function and liver fat in overweight and obese adults with elevated fasting blood glucose: A randomised controlled trial. Clin. Nutr. Espen. 2019, 30, 10–18. [Google Scholar] [CrossRef] [PubMed]
- Hamid, A.S.; Tesfamariam, I.G.; Zhang, Y.; Zhang, Z.G. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention (Review). Oncol. Lett. 2013, 5, 1087–1092. [Google Scholar] [CrossRef] [Green Version]
- EFSA Panel on Contaminants in the Food Chain; Schrenk, D.; Bignami, M.; Bodin, L.; Chipman, J.K.; Del Mazo, J.; Grasl-Kraupp, B.; Hogstrand, C.; Hoogenboom, L.R.; Leblanc, J.C.; et al. Risk assessment of aflatoxins in food. EFSA J. 2020, 18, e06040. [Google Scholar] [CrossRef]
- Marin, S.; Ramos, A.J.; Cano-Sancho, G.; Sanchis, V. Mycotoxins: Occurrence, toxicology, and exposure assessment. Food Chem. Toxicol. 2013, 60, 218–237. [Google Scholar] [CrossRef]
- Kabak, B. Prevention and Management of Mycotoxins in Food and Feed. Mycotoxins Food Feed Bioweapons 2010, 201–227. [Google Scholar] [CrossRef]
- International Agency for Research on Cancer. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Available online: http://monographs.iarc.fr/ENG/Monographs/vol82/volume82.pdf (accessed on 16 September 2020).
- Berg, T. How to establish international limits for mycotoxins in food and feed? Food Control 2003, 14, 219–224. [Google Scholar] [CrossRef]
- Diella, G.; Caggiano, G.; Ferrieri, F.; Ventrella, A.; Palma, M.; Napoli, C.; Rutigliano, S.; Lopuzzo, M.; Lovero, G.; Montagna, M.T. Aflatoxin contamination in nuts marketed in Italy: Preliminary results. Ann. Ig. 2018, 30, 401–409. [Google Scholar] [CrossRef]
- Park, D.L.; Liang, B. Perspectives on aflatoxin control for human food and animal feed. Trends Food Sci. Technol. 1993, 4, 334–342. [Google Scholar] [CrossRef]
- Cheraghali, A.M.; Yazdanpanah, H.; Doraki, N.; Abouhossain, G.; Hassibi, M.; Ali-abadi, S.; Aliakbarpoor, M.; Amirahmadi, M.; Askarian, A.; Fallah, N.; et al. Incidence of aflatoxins in Iran pistachio nuts. Food Chem. Toxicol. 2007, 45, 812–816. [Google Scholar] [CrossRef] [PubMed]
- Ding, X.; Li, P.; Bai, Y.; Zhou, H. Aflatoxin B1 in post-harvest peanuts and dietary risk in China. Food Control 2012, 23, 143–148. [Google Scholar] [CrossRef]
- European Food Safety Authority. Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances which are both Genotoxic and Carcinogenic. EFSA J. 2005, 3, 282. [Google Scholar] [CrossRef] [Green Version]
- Evaluation of Certain Food Additives and Contaminants. Forty-ninth report of the Joint FAO/WHO Expert Committee on Food Additives; World Health Organization: Geneva, Switzerland, 1999.
- Andrade, P.; Caldas, E. Aflatoxins in cereals: Worldwide occurrence and dietary risk assessment. World Mycotoxin J. 2015, 8, 415–431. [Google Scholar] [CrossRef]
- Torres, M.C.P.; Bodini, G.; Furnari, M.; Marabotto, E.; Zentilin, P.; Strazzabosco, M.; Giannini, E.G. Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective? Cancers 2020, 12, 1422. [Google Scholar] [CrossRef]
- Kanwal, F.; Kramer, J.R.; Mapakshi, S.; Natarajan, Y.; Chayanupatkul, M.; Richardson, P.A.; Li, L.; Desiderio, R.; Thrift, A.P.; Asch, S.M.; et al. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology 2018, 155, 1828–1837.e2. [Google Scholar] [CrossRef] [Green Version]
- Kulik, L.; El-Serag, H.B. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology 2019, 156, 477–491.e1. [Google Scholar] [CrossRef] [PubMed]
- Anstee, Q.M.; Reeves, H.L.; Kotsiliti, E.; Govaere, O.; Heikenwalder, M. From NASH to HCC: Current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 411–428. [Google Scholar] [CrossRef] [PubMed]
- Hsu, I.C.; Metcalf, R.A.; Sun, T.; Welsh, J.A.; Wang, N.J.; Harris, C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991, 350, 427–428. [Google Scholar] [CrossRef] [PubMed]
- Mohsenzadeh, M.S.; Hedayati, N.; Riahi-Zanjani, B.; Karimi, G. Immunosuppression following dietary aflatoxin B1 exposure: A review of the existing evidence. Toxin Rev. 2016, 35, 121–127. [Google Scholar] [CrossRef]
- Hu, Z.Q.; Xin, H.Y.; Luo, C.B.; Li, J.; Zhou, Z.J.; Zou, J.X.; Zhou, S.L. Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma. Cancer Immunol. Immunother. 2020. [Google Scholar] [CrossRef] [PubMed]
- Luyendyk, J.P.; Shores, K.C.; Ganey, P.E.; Roth, R.A. Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: Benchmark dose analysis for markers of liver injury. Toxicol. Sci. 2002, 68, 220–225. [Google Scholar] [CrossRef] [Green Version]
- Barton, C.C.; Barton, E.X.; Ganey, P.E.; Kunkel, S.L.; Roth, R.A. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha. Hepatology 2001, 33, 66–73. [Google Scholar] [CrossRef]
- Gao, Y.; Meng, L.; Liu, H.; Wang, J.; Zheng, N. The Compromised Intestinal Barrier Induced by Mycotoxins. Toxins 2020, 12, 619. [Google Scholar] [CrossRef]
- Nugraha, A.; Khotimah, K.; Rietjens, I.M.C.M. Risk assessment of aflatoxin B1 exposure from maize and peanut consumption in Indonesia using the margin of exposure and liver cancer risk estimation approaches. Food Chem. Toxicol. 2018, 113, 134–144. [Google Scholar] [CrossRef] [PubMed]
- Johnson, N.M.; Qian, G.; Xu, L.; Tietze, D.; Marroquin-Cardona, A.; Robinson, A.; Rodriguez, M.; Kaufman, L.; Cunningham, K.; Wittmer, J.; et al. Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma. Sci. Total Environ. 2010, 408, 6027–6031. [Google Scholar] [CrossRef] [Green Version]
- Van de Perre, E.; Jacxsens, L.; Lachat, C.; El Tahan, F.; De Meulenaer, B. Impact of maximum levels in European legislation on exposure of mycotoxins in dried products: Case of aflatoxin B1 and ochratoxin A in nuts and dried fruits. Food Chem. Toxicol. 2015, 75, 112–117. [Google Scholar] [CrossRef] [PubMed]
- Eneroth, H.; Wallin, S.; Leander, K.; Nilsson Sommar, J.; Åkesson, A. Risks and Benefits of Increased Nut Consumption: Cardio-vascular Health Benefits Outweigh the Burden of Carcinogenic Effects Attributed to Aflatoxin B1 Exposure. Nutrients 2017, 9, 1355. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sui, J.; Yang, W.; Ma, Y.; Li, T.Y.; Simon, T.G.; Meyerhardt, J.A.; Liang, G.; Giovannucci, E.L.; Chan, A.T.; Zhang, X. A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men. Cancer Prev. Res. 2019, 12, 367–374. [Google Scholar] [CrossRef]
Beneficial Effects of Nuts |
---|
|
|
|
|
|
|
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Plaz Torres, M.C.; Bodini, G.; Furnari, M.; Marabotto, E.; Zentilin, P.; Giannini, E.G. Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease? Nutrients 2020, 12, 3363. https://doi.org/10.3390/nu12113363
Plaz Torres MC, Bodini G, Furnari M, Marabotto E, Zentilin P, Giannini EG. Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease? Nutrients. 2020; 12(11):3363. https://doi.org/10.3390/nu12113363
Chicago/Turabian StylePlaz Torres, Maria Corina, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Patrizia Zentilin, and Edoardo G. Giannini. 2020. "Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?" Nutrients 12, no. 11: 3363. https://doi.org/10.3390/nu12113363
APA StylePlaz Torres, M. C., Bodini, G., Furnari, M., Marabotto, E., Zentilin, P., & Giannini, E. G. (2020). Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease? Nutrients, 12(11), 3363. https://doi.org/10.3390/nu12113363